Healthcare

As the Healthcare sector emerges from a time of immense pressure and high visibility, we see huge investment, potential and opportunity ahead

Truly dynamic and innovative at its core, Healthcare is poised for a period of growth and transformation. Driven by a range of factors – including Covid-19; greater emphasis on personalisation; digitisation and technological innovation; changing demographics; and shifting customer and patient expectations – organisations of all sizes and ownership structures seek the right leaders to seize this opportunity.

Supporting clients at Board, Executive Committee and leadership levels, we combine extensive experience in and a deep understanding of the wide and varied Healthcare sector, including its clinical leadership, as well as access to relevant talent pools in adjacent consumer-facing industries.

View current opportunities

The MBS Group acts as an advisor to NHS and other public sector bodies on senior appointments. To view current appointments, click here.

Our Experience

Clinical Services

Life Sciences
HealthTech & Digital Healthcare
Insurers
Healthcare Systems
Medical Devices & Diagnostics

Selected Clients

Latest MBS News & Intelligence

Thriva partners with medical device manufacturer, Tasso for ‘needle free’ blood testing. The blood testing company has partnered with Tasso, to offer ‘needle-free’ at-home blood testing. The device aims to make blood testing accessible by attaching to the top of the arm and deploying a lancet into the skin at the press of the button.
Ezra launches AI-powered full body MRI scan in the UK. The healthcare technology company has launched the system which assesses 13 organs and detects over 500 conditions within a single 60-minute session, reducing scan times and enhancing radiology workflows. It plans to roll-out nationwide later this year.
Phantom Neuro secures $19m of funding. The startup, which is developing a wristband-like device that lets a person control prosthetic limbs, has raised the funding for its next stage of development. Participating investors include Breakout Ventures, Draper Associates and Intel.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.